A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.
Browsing: Research
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
A new Northwestern Medicine study highlighted for the first time how a toxin from the extracellular bacterium Vibrio cholerae can inhibit autophagy and endosomal trafficking.
Blocking the sodium channel protein Nax decreased scarring and atopic dermatitis, an inflammatory skin disorder, by improving the skin’s barrier function in a new Northwestern Medicine study.
The Fifth Annual Les Turner Symposium on ALS and NeuroRepair celebrated a new research and clinical care center and featured a variety of presentations, a keynote lecture and a poster session.
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
Marcus Peter, PhD, professor of Medicine in the Division of Hematology/Oncology, and Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, and Maciej Lesniak, MD, chair of Neurological Surgery, have each been awarded seven-year, $6.4 million grants from the National Cancer Institute.